Axq Capital, LP Acadia Pharmaceuticals Inc Transaction History

Axq Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$14.62 - $18.42 $42,412 - $53,436	2,901 Added 17.29%	19,680 $320 Million
Q1 2024 May 14, 2024	BUY	$17.79 - $30.86 $147,265 - $255,459	8,278 Added 97.38%	16,779 $310 Million
Q4 2023 Feb 13, 2024	SELL	$20.78 - $31.77 $229,619 - $351,058	-11,050 Reduced 56.52%	8,501 $266 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $407,442 - $654,371	19,551 New	19,551 $407 Million
Q1 2023 May 10, 2023	BUY	$16.32 - $20.92 $201,372 - $258,131	12,339 New	12,339 $232 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Axq Capital, LP with notifications on news.